Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.
about
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in miceOxaliplatin-induced loss of phosphorylated heavy neurofilament subunit neuronal immunoreactivity in rat DRG tissue.Safety studies on intravenous infusion of a potent angiogenesis inhibitor: taurocholate-conjugated low molecular weight heparin derivative LHT7 in preclinical models.Impact of Laparotomy and Intraperitoneal Hyperthermic Instillation (LIHI) on the oxaliplatin pharmacokinetics after intravenous administration in Wistar rats.
P2860
Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Dosing sequence-dependent phar ...... in with paclitaxel in the rat.
@en
Dosing sequence-dependent phar ...... in with paclitaxel in the rat.
@nl
type
label
Dosing sequence-dependent phar ...... in with paclitaxel in the rat.
@en
Dosing sequence-dependent phar ...... in with paclitaxel in the rat.
@nl
prefLabel
Dosing sequence-dependent phar ...... in with paclitaxel in the rat.
@en
Dosing sequence-dependent phar ...... in with paclitaxel in the rat.
@nl
P2093
P1476
Dosing sequence-dependent phar ...... in with paclitaxel in the rat.
@en
P2093
Eric H Kraut
Kenneth K Chan
Michael Grever
Stanley Balcerzak
Steven D'Ambrosio
P2888
P304
P356
10.1007/S00280-002-0531-6
P577
2002-10-16T00:00:00Z